Innohep

Innohep®

See Tinzaparin.

Innohep

A brand name for TINZAPARIN.
References in periodicals archive ?
Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): Anti-Xa and anti-IIa activities over 10 days.
Further, of these LMWHs, the experience with tinzaparin sodium (Innohep, Leo Pharmaceutical Corp.) is limited [12, 15, 24].
You can manage DVT with LMWH--dalteparin (Fragmin), enoxaparin (Lovenox), or tinzaparin (Innohep)--or the factor Xa inhibitor fondaparinux (Arixtra) overlapped with warfarin (Coumadin).
Common pharmacologicals used in DVT prophylaxis include Innohep, Orgaran and Clexane (New Ethicals Compendium 2004).
The three available LMWH products, dalteparin (Fragmin), enoxaparin (Lovenox), and tinzaparin (Innohep), and a low-molecular-weight heparinoid, danaparoid, are rated B, because animal reproduction studies have found no evidence of fetal harm.
There are two other low-molecular-weight heparins approved in the United States, dalteparin (Fragmin, manufactured by Pharmacia) and tinzaparin (Innohep, manufactured by DuPont Pharma Inc.).
The following anticoagulants were used: (a) UFH (Heparin Leo, 5000 IU/mL; Leo Pharmaceutical Products) with an average molecular weight of 12 000-15 000; (b) LMWH (Innohep,[R] 10 000 anti-Xa [7] IU/mL; Leo Pharmaceutical Products) with an average molecular weight of 2500-6000; and (c) trisodium citrate (1.2 mol/L; Sterop SA).
Innohep is used off-label with postoperative patients for treatment of VTE in this institution.
Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venografic controlled study.